Cargando…
A novel facet of tumor suppression by p53: Induction of tumor immunogenicity
Pharmacological reactivation of the p53 tumor suppressor is a promising strategy for anti-cancer therapy due to its high potential to elicit apoptosis or growth arrest in cancer cells. Recently we uncovered the mechanism of activation of the innate immune response by p53 upon its activation by small...
Autores principales: | Li, Hai, Lakshmikanth, Tadepally, Carbone, Ennio, Selivanova, Galina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382884/ https://www.ncbi.nlm.nih.gov/pubmed/22754780 |
Ejemplares similares
-
PBRM1 suppresses tumor growth as a novel p53 acetylation reader
por: Cai, Weijia, et al.
Publicado: (2020) -
Oxysterols recruit tumor-supporting neutrophils within the tumor microenvironment: The many facets of tumor-derived oxysterols
por: Raccosta, Laura, et al.
Publicado: (2013) -
Warming up the tumor microenvironment in order to enhance immunogenicity
por: Humbert, Marion, et al.
Publicado: (2018) -
Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting
por: Kono, Koji, et al.
Publicado: (2013) -
Tumor suppression by stromal TIMPs
por: Shimoda, Masayuki, et al.
Publicado: (2016)